Administration of ENBREL should be discontinued if a patient develops a serious infection. Caution should be exercised when considering the use of ENBREL in patients with a history of recurring or ...

Enbrel (etanercept) is a prescription drug that’s used to manage certain inflammatory conditions. The drug comes as a liquid solution that’s injected under your skin. It’s usually given once or twice ...

The safety of etanercept in this patient population was established through multiple pediatric trials, including a clinical study in 69 children aged 2 to 17 years with moderately to severely active ...

SEATTLE, WA – Immunex Corporation (Nasdaq: IMNX) and Wyeth-Ayerst Laboratories, a division of American Home Products (NYSE: AHP) announced today that the U.S. Food and Drug Administration (FDA) has ...

Alert Enbrel (etanercept) - Reports of Adverse Events In order to help reduce difficulties experienced by some patients when self-administering ENBREL (etanercept), we are writing to ask for your ...

Oct. 14, 2004 — The U.S. Food and Drug Administration (FDA) has approved caspofungin acetate for the empiric treatment of presumed fungal infections in the setting of febrile neutropenia, etanercept ...

The needle stays hidden during injection and a sensor can detect placement on skin. It also includes 3 difference injection speeds, a progress bar and a speaker. Amgen announced the availability of ...

To access further media information relating to this press release, additional information on ENBREL and future media announcements, please register on the media ...

THOUSAND OAKS, Calif. & COLLEGEVILLE, Pa. -- Amgen and Wyeth Pharmaceuticals, a division of Wyeth, today announced updates to the U.S. Food and Drug Administration (FDA)-approved U.S. Prescribing ...

The US Food and Drug Administration has approved Sandoz' biosimilar of Amgen's blockbuster Enbrel. The US Food and Drug Administration has approved Sandoz’ biosimilar of Amgen’s blockbuster Enbrel.